Nordsmark M - Search Results

1

Dosimetric evaluation of anatomical changes during treatment to identify criteria for adaptive radiotherapy in oesophageal cancer patients.

Nyeng TB, Nordsmark M, Hoffmann L. Nyeng TB, et al. Among authors: nordsmark m. Acta Oncol. 2015;54(9):1467-73. doi: 10.3109/0284186X.2015.1068449. Epub 2015 Jul 29. Acta Oncol. 2015. PMID: 26223492

2

Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer.

Nordsmark M, Overgaard J. Nordsmark M, et al. Acta Oncol. 2004;43(4):396-403. doi: 10.1080/02841860410026189. Acta Oncol. 2004. PMID: 15303502

3

Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.

Mortensen LS, Buus S, Nordsmark M, Bentzen L, Munk OL, Keiding S, Overgaard J. Mortensen LS, et al. Among authors: nordsmark m. Acta Oncol. 2010 Oct;49(7):934-40. doi: 10.3109/0284186X.2010.516274. Acta Oncol. 2010. PMID: 20831480

4

Daily cone-beam computed tomography used to determine tumour shrinkage and localisation in lung cancer patients.

Knap MM, Hoffmann L, Nordsmark M, Vestergaard A. Knap MM, et al. Among authors: nordsmark m. Acta Oncol. 2010 Oct;49(7):1077-84. doi: 10.3109/0284186X.2010.498434. Acta Oncol. 2010. PMID: 20831499

5

Hypoxia-regulated gene expression and prognosis in loco-regional gastroesophageal cancer.

Winther M, Alsner J, Tramm T, Nordsmark M. Winther M, et al. Among authors: nordsmark m. Acta Oncol. 2013 Oct;52(7):1327-35. doi: 10.3109/0284186X.2013.818247. Epub 2013 Aug 19. Acta Oncol. 2013. PMID: 23957682

6

PET imaging of tumor hypoxia using 18F-labeled pimonidazole.

Busk M, Jakobsen S, Horsman MR, Mortensen LS, Iversen AB, Overgaard J, Nordsmark M, Ji X, Lee DY, Raleigh JR. Busk M, et al. Among authors: nordsmark m. Acta Oncol. 2013 Oct;52(7):1300-7. doi: 10.3109/0284186X.2013.815797. Epub 2013 Aug 21. Acta Oncol. 2013. PMID: 23962243

7

Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.

Winther M, Alsner J, Tramm T, Baeksgaard L, Holtved E, Nordsmark M. Winther M, et al. Among authors: nordsmark m. Acta Oncol. 2015;54(9):1582-91. doi: 10.3109/0284186X.2015.1064161. Acta Oncol. 2015. PMID: 26481465

8

Prognostic value of hypoxia-regulated gene expression in loco-regional gastroesophageal cancer.

Winther M, Alsner J, Tramm T, Holtved E, Baeksgaard L, Nordsmark M. Winther M, et al. Among authors: nordsmark m. Acta Oncol. 2016 May;55(5):652-5. doi: 10.3109/0284186X.2015.1114680. Epub 2015 Dec 1. Acta Oncol. 2016. PMID: 26623712 No abstract available.

9

Validation of a robust strategy for proton spot scanning for oesophageal cancer in the presence of anatomical changes.

Møller DS, Alber M, Nordsmark M, Nyeng TB, Lutz CM, Hoffmann L. Møller DS, et al. Among authors: nordsmark m. Radiother Oncol. 2019 Feb;131:174-178. doi: 10.1016/j.radonc.2018.09.018. Epub 2018 Oct 16. Radiother Oncol. 2019. PMID: 30340776

10

Setup strategies and uncertainties in esophageal radiotherapy based on detailed intra- and interfractional tumor motion mapping.

Hoffmann L, Poulsen PR, Ravkilde T, Bertholet J, Kruhlikava I, Helbo BL, Schmidt ML, Nordsmark M. Hoffmann L, et al. Among authors: nordsmark m. Radiother Oncol. 2019 Jul;136:161-168. doi: 10.1016/j.radonc.2019.04.014. Epub 2019 Apr 20. Radiother Oncol. 2019. PMID: 31015120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

87 results

Search Page

Filters